Full Text
Cost of Care with Everolimus Versus Axitinib for Second-Line Metastatic Renal Cell Carcinoma Patients in Canada

Abstract

Authors

A. Perrin A. Chua X. Wang M. Hurry

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×